Located in Columbia, Md., Osiris Therapeutics (OSIR) is a leader in regenerative medicine. Osiris is currently re-emerging from a turbulent period of time of delayed financials, delisting from the Nasdaq, and outstanding litigation.
Financials Confirm Osiris Continues to Grow
On March 28, 2018, Osiris provided financials for 2015, 2016, and 2017. Beyond getting financials current with the SEC, the financials show Osiris Therapeutics continued to grow during the tumultuous years. The company's growth happened despite all the distractions, which diverted time, money, and effort away from the daily business.
Revenues have grown from $7.1 million